May 18, 2019

Practical Guidance on the Use of Lurasidone for the Treatment of Adults with Schizophrenia

Neurology and Therapy
Afzal JavedSofia Pappa


Lurasidone is an atypical antipsychotic that was approved in Europe in 2014 for the treatment of schizophrenia in adults aged ≥ 18 years. Clinical experience with lurasidone in Europe is currently limited, and there is therefore a need to provide practical guidance on using lurasidone for the treatment of adults with schizophrenia. A panel of European psychiatrists with extensive experience of prescribing lurasidone was convened to provide recommendations on using lurasidone to treat adults with schizophrenia. Extensive evidence from clinical trials and the panel's clinical experience suggest that lurasidone is as effective as other atypical agents, with the possible exception of clozapine. Lurasidone is associated with a lower propensity for metabolic side effects (in particular, weight gain) and hyperprolactinaemia than most other atypical antipsychotics and has a relatively benign neurocognitive side effect profile. Patients switching to lurasidone from another antipsychotic may experience weight reduction and/or improvements in the ability to focus/concentrate. Most side effects with lurasidone (such as somnolence) are transitory, easily managed and/or ameliorated by dose adjustment. Akathisia and extrapyramidal symptoms ma...Continue Reading

  • References2
  • Citations1


  • References2
  • Citations1


Mentioned in this Paper

Ortho Pharmaceutical Ltd
Adverse Effects
Antipsychotic Agents
Pharmacologic Substance
Clinical Trials

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists
Australian Prescriber
The Journal of Clinical Psychiatry
John M Kane
Expert Review of Neurotherapeutics
Joshua T Kantrowitz, Leslie Citrome
© 2020 Meta ULC. All rights reserved